CIA
NUVA

CSat Investment Advisory’s NuVasive, Inc. NUVA Stock Holding History

CSat Investment Advisory’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-572
Closed -$28K – 1013
2020
Q3 		$28K Buy
572
+68
+13% +$3.66K ﹤0.01% 781
2020
Q2 		$28K Buy
+504
New +$29.2K ﹤0.01% 760

Other funds holding NUVA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ACA
Anchor Capital Advisors Boston, Massachusetts $3.56B AUM 21.74% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

CSat Investment Advisory's NUVA Position: Q4 2020 in Review

CSat Investment Advisory sold out of NuVasive, Inc. (NUVA) in Q4 2020, closing a stake of 572 shares — an estimated $28K sold.

CSat Investment Advisory first reported a position in NUVA in Q2 2020 and held it in 2 quarters. The position peaked at $28K in Q3 2020. 280 funds tracked by Wall St. Rank hold NUVA as of Q4 2020.

  • CSat Investment Advisory reported no remaining NuVasive, Inc. position as of Q4 2020 after selling out during the quarter.
  • CSat Investment Advisory sold 572 NuVasive, Inc. shares in Q4 2020, an estimated $28K.
  • CSat Investment Advisory first reported a position in NuVasive, Inc. in Q2 2020 and held it in 2 quarters.
  • CSat Investment Advisory's NuVasive, Inc. position peaked at $28K in Q3 2020.
  • 280 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q4 2020.

Based on CSat Investment Advisory's 13F filing for Q4 2020, filed 12 Feb 2021.